| 11th Jan 2019 7:00 am |
RNS |
Publication of VAL401 peer-reviewed article |
| 9th Jan 2019 10:41 am |
RNS |
ValiRx endorses the Government's new NHS strategy |
| 3rd Jan 2019 7:00 am |
RNS |
Holding(s) in Company |
| 18th Dec 2018 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 18th Dec 2018 4:36 pm |
RNS |
Price Monitoring Extension |
| 18th Dec 2018 11:25 am |
RNS |
Issue of Equity / PDMR Shareholdings |
| 18th Dec 2018 7:00 am |
RNS |
Update on VAL401 - Peer-review Acceptance |
| 10th Dec 2018 7:00 am |
RNS |
Update on VAL201 Clinical Trial |
| 5th Nov 2018 7:00 am |
RNS |
Re scientific and investor meetings |
| 1st Nov 2018 7:15 am |
EQS |
Hardman & Co Research: ValiRx (VAL): VAL401 Phase II trial completed |
| 24th Oct 2018 7:00 am |
RNS |
Align Research Initiates Coverage |
| 17th Oct 2018 7:00 am |
RNS |
VAL201 in concluding stages of Phase I/II trial |
| 15th Oct 2018 12:00 pm |
RNS |
VAL401 results shortly to be on ClinicalTrials.gov |
| 25th Sep 2018 7:00 am |
RNS |
Half-year Report |
| 14th Sep 2018 12:42 pm |
RNS |
Issue of Equity |
| 6th Sep 2018 7:00 am |
RNS |
Update on Clinical Development |
| 24th Jul 2018 12:17 pm |
RNS |
Result of General Meeting |
| 17th Jul 2018 7:00 am |
RNS |
US PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301 |
| 6th Jul 2018 4:42 pm |
RNS |
Notice of GM |
| 14th Jun 2018 7:00 am |
RNS |
VAL401 Update |
| 24th May 2018 9:00 am |
RNS |
Price Monitoring Extension |
| 11th May 2018 2:56 pm |
RNS |
Holding(s) in Company |
| 8th May 2018 12:13 pm |
RNS |
Result of AGM |
| 4th May 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 4th May 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 4th May 2018 4:01 pm |
RNS |
Placing and grant of warrants |
| 26th Apr 2018 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 26th Apr 2018 2:00 pm |
RNS |
Price Monitoring Extension |
| 25th Apr 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 25th Apr 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 25th Apr 2018 7:00 am |
RNS |
EU Patent Grant for Therapeutic Compound, VAL201 |
| 20th Apr 2018 10:45 am |
EQS |
Hardman & Co Research: ValiRx (VAL): 2017: a pivotal year |
| 19th Apr 2018 7:00 am |
RNS |
GENEICE & VAL101 Update |
| 12th Apr 2018 7:00 am |
RNS |
Notice of AGM |
| 10th Apr 2018 7:00 am |
RNS |
Final Results |
| 20th Mar 2018 7:00 am |
RNS |
US Patent Grant for Therapeutic Compound, VAL201 |
| 19th Mar 2018 7:00 am |
RNS |
Holding(s) in Company |
| 16th Mar 2018 3:01 pm |
RNS |
Appointment of Broker |
| 2nd Mar 2018 11:01 am |
RNS |
Statement re broker |
| 9th Feb 2018 11:57 am |
RNS |
Issue of options and directors dealings |
